Preview

Научно-практическая ревматология

Расширенный поиск

Патология периодонта и системные васкулиты: взгляд сквозь призму междисциплинарных исследований

https://doi.org/10.14412/1995-4484-2017-685-689

Полный текст:

Аннотация

Обзор посвящен исследованиям, направленным на изучение взаимосвязи патологии периодонта (ПП) и хронического аутоиммунного воспалительного ответа, к наиболее ярким моделям которого относят системные васкулиты (СВ). Заболевания периодонта ассоциируются с системным воспалением и сосудистой патологией, что характеризуется эндотелиальной дисфункцией и существенным риском кардиоваскулярных и цереброваскулярных заболеваний, сахарного диабета, аутоиммунных болезней. Обсуждается перспективность междисциплинарных исследований, направленных на изучение биологических эффектов ПП при СВ и других ревматических заболеваниях.

 

Об авторах

Т. В. Бекетова
ФГБНУ «Научно- исследовательский институт ревматологии им. В.А. Насоновой», Москва
Россия


Е. И. Селифанова
ФГБНУ «Научно- исследовательский институт ревматологии им. В.А. Насоновой», Москва
Россия


Список литературы

1. De Pablo P, Chapple IL, Buckley CD, Dietrich T. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol. 2009;5(4):218-24. doi: 10.1038/nrrheum.2009.28

2. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1-11. doi: 10.1002/art.37715

3. Saffi MAL, Furtado MV, Polanczyk CA, et al. Relationship between vascular endothelium and periodontal disease in athero-sclerotic lesions: Review article. World J Cardiol. 2015;7(1):26-30. doi: 10.4330/wjc.v7.i1.26

4. Dietrich T, Jimenez M, Krall Kaye EA, et al. Age-dependent associations between chronic periodontitis/edentulism and risk of coronary heart disease. Circulation. 2008;117(13):1668-74.

5. doi: 10.1161/CIRCULATIONAHA.107.711507

6. Aarabi G, Eberhard J, Reissmann DR, et al. Interaction between periodontal disease and atherosclerotic vascular disease – Fact or fiction? Atherosclerosis. 2015;241(2):555-60. doi: 10.1016/j.atherosclerosis.2015.04.819

7. Nesse W, Dijkstra PU, Abbas F, et al. Increased prevalence of cardiovascular and autoimmune diseases in periodontitis patients: a cross-sectional study. J Periodontol. 2010;81(11):1622-8. doi: 10.1902/jop.2010.100058

8. Mercado FB, Marshall RI, Bartold PM. Inter-relationships between rheumatoid arthritis and periodontal disease. A review. J Clin Periodontol. 2003;30(9):761-72. doi: 10.1034/j.1600-051X.2003.00371.x

9. Brook I. Microbiology and management of periodontal infections. Gen Dent. 2003;51(5):424-8.

10. Nair S, Faizuddin M, Dharmapalan J. Role of autoimmune responses in periodontal disease. Autoimmun Dis. 2014;2014:596824. doi: 10.1155/2014/596824

11. Sharma CG, Pradeep AR. Anti-neutrophil cytoplasmic autoanti-bodies: a renewed paradigm in periodontal disease pathogenesis? J Periodontol. 2006;77(8):1304-13. doi: 10.1902/jop.2006.050308

12. Takeuchi Y, Yoshie H, Hara K. Expression of interleukin-2 receptor and HLA-DR on lymphocyte subsets of gingival crevicular fluid in patients with periodontitis. J Periodont Res. 1991;26(6):502-10. doi: 10.1111/j.1600-0765.1991.tb01802.x

13. Sugawara M, Yamashita K, Yoshie H, Hara K. Detection of, and anti-collagen antibody produced by, CD5-positive B cells in inflamed gingival tissues. J Periodont Res. 1992;27(5):489-98. doi: 10.1111/j.1600-0765.1992.tb01822.x

14. D'Aiuto F, Graziani F, Tete S, et al. Periodontitis: from local infection to systemic diseases. Int J Immunopathol Pharmacol. 2005;18(3 Suppl):1-11.

15. Arigbede AO, Babatope BO, Bamidele MK. Periodontitis and systemic diseases: A literature review. J Indian Soc Periodontol. 2012;16(4):487-91. doi: 10.4103/0972-124X.106878

16. Scannapieco FA, Bush RB, Paju S. Periodontal disease as a risk factor for adverse pregnancy outcome: A systematic review. Ann Periodontol. 2003;8:70-8. doi: 10.1902/annals.2003.8.1.70

17. Slade GD, Ghezzi EM, Heiss G, et al. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med. 2003;163(10):1172-9. doi: 10.1001/archinte.163.10.1172

18. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol. 2005;76(11 Suppl):2106-15.

19. doi: 10.1902/jop.2005.76.11-S.2106

20. Chukkapalli SS, Rivera-Kweh MF, Velsko IM, et al. Chronic oral infection with major periodontal bacteria Tannerella forsythia modulates systemic atherosclerosis risk factors and inflammatory markers. Pathogen Dis. 2015;73(3). doi: 10.1093/femspd/ftv009

21. Haraszthy V, Zambon J, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000;71(10):1554-60. doi: 10.1902/jop.2000.71.10.1554

22. Willershausen B, Kasaj A, Willershausen I, et al. Association between chronic dental infection and acute myocardial infarction. J Endodont. 2009;35(5):626-30. doi: 10.1016/j.joen.2009.01.012

23. Mendall MA, Patel P, Ballan L, et al. C-reactive protein and its relation to cardiovascular risk factor: a population based cros-section study. Brit Med J. 1996;312:1061-5. doi: 10.1136/bmj.312.7038.1061

24. Banks M, Flint J, Bacon P, Kitas G. Rheumatoid arthritis is an independent risk factor for ischemic heart disease. Arthritis Rheum. 2000;43 Suppl:385.

25. Hollan I, Meroni PL, Ahearn JM, et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev. 2013;12:1004-15. doi: 10.1016/j.autrev.2013.03.013

26. Ridker PM. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation. 1998;97(17):1671-4. doi: 10.1161/01.CIR.97.17.1671

27. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997;96(7):2144-8.

28. doi: 10.1161/01.CIR.96.7.2144

29. Wiedermann CJ, Kiechl S, Dunzendorfer S, et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results for the Brunek study. J Am Coll Cardiol. 1999;34:1975-81. doi: 10.1016/S0735-1097(99)00448-9

30. Etemadifar R, Konarizadeh S, Zarei A, et al. Relationship between periodontal status and C-reactive protein and inter-leuckin-6 levels among atherosclerotic patients in Bandar Abbas, Iran in 2014. Electr Phys. 2015;7(1):1010-6.

31. Glurich I, Grossi S, Albini B, et al. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol. 2002;9(2):425-32. doi: 10.1128/CDLI.9.2.425-432.2002

32. Pradeep AR, Hadge P, Arjun Raju P, et al. Periodontitis as a risk factor for cerebrovascular accident: a case-control study in the Indian population. J Periodontal Res. 2010;45(2):223-8. doi: 10.1111/j.1600-0765.2009.01220.x

33. Janket SJ, Qvarnströ m M, Meurman JH, et al. Asymptotic dental score and prevalent coronary heart disease. Circulation. 2004;109(9):1095-100. doi: 10.1161/01.CIR.0000118497.44961.1E

34. Vettore MV, Leal M, Leao AT, et al. The Relationship between Periodontitis and Preterm Low Birth weight. J Dent Res. 2008;87:73-8. doi: 10.1177/154405910808700113

35. Goldenberg RL, Culhane JF. Preterm Birth and Periodontal Disease. N Engl J Med. 2006;355:1925-7. doi: 10.1056/NEJMe068210

36. Offenbacher S, Boggess KA, Murtha AP, et al. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol. 2006;107:29-36. doi: 10.1097/01.AOG.0000190212.87012.96

37. Pitiphat W, Joshipura K, Gillman MW, et al. Maternal periodonti-tis and adverse pregnancy outcomes. Community Dent Oral Epidemiol. 2008;36:3-11.

38. Xiong X, Elkind-Hirsch KE, Vastardis S, et al. Periodontal disease is associated with gestational diabetes mellitus: a case-control study. J Periodontol. 2009;80(11):1742-9. doi: 10.1902/jop.2009.090250

39. Negrato CA, Tarzia O, Jovanovic L, Chinellato LE. Periodontal disease and diabetes mellitus. J Appl Oral Sci. 2013;21(1):1-12. doi: 10.1590/1678-7757201302106

40. Dunning T. Periodontal disease – the overlooked diabetes complication. Nephrol Nurs J. 2009;36(5):489-95.

41. Iacopino AM. Periodontitis and diabetes interrelationships: Role of inflammation. Ann Periodontol. 2001;6:125-37.

42. doi: 10.1902/annals.2001.6.1.125

43. Mealey BL, Rose LF. Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes. 2008;15:135-41. doi: 10.1097/MED.0b013e3282f824b7

44. Rosenquist K. Risk factors in oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden. Swed Dent J. 2005;179:1-66.

45. Michaud DS, Liu Y, Meyer M, et al. Periodontal disease, tooth loss, and cancer risk in male health professionals: A prospective cohort study. Lancet Oncol. 2008;9:550-8. doi: 10.1016/S1470-2045(08)70106-2

46. Tezal M, Sullivian MA, Hyland A, et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18:2409-12. doi: 10.1158/1055-9965.EPI-09-0334

47. Soory M. Periodontal diseases and rheumatoid arthritis: a coincident model for therapeutic intervention? Curr Drug Metab. 2007;8(8):750-7. doi: 10.2174/138920007782798162

48. Liao F, Li Z, Wang Y, et al. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis. Med Hypoth. 2009;72(6):732-5.

49. doi: 10.1016/j.mehy.2008.12.040

50. Arkema EV, Karlson EW, Costenbader KH. A prospective study of periodontal disease and risk of rheumatoid arthritis. J Rheumatol. 2010;37(9):1800-4. doi: 10.3899/jrheum.091398

51. Hitchon C, Chandad F, Ferucci E, et al. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. Rheumatology. 2010;37(6):1105-12. doi: 10.3899/jrheum.091323

52. Bartold P, Marino V, Cantley M, et al. Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J Clin Periodontol. 2010;37(5):405-11.

53. doi: 10.1111/j.1600-051X.2010.01552.x

54. Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol. 2010;6(12):727-30. doi: 10.1038/nrrheum.2010.139

55. Katz J, Goultschin J, Benoliel R, Brautbar C. Human leukocyte antigen (HLA) DR4. Positive association with rapidly progressing periodontitis. J Periodontol. 1987;58:607-10. doi: 10.1902/jop.1987.58.9.607

56. Bonfil JJ, Dillier FL, Mercier P, et al. A «case control» study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PcR.SSO). J Clin Periodontol. 1999;26:77-84. doi: 10.1034/j.1600-051X.1999.260203.x

57. Dingle JT, Leeming MRG, Martindale JJ. Effect of Tenidap on cartilage integrity in vitro. Ann Rheum Dis. 1993;52:292-9.

58. doi: 10.1136/ard.52.4.292

59. Weyand C, McCarthy T, Goronzy J. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest. 1995;95:2120-6. doi: 10.1172/JCI117900

60. Marotte H, Farge P, Gaudin P, et al. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Ann Rheum Dis. 2006;65:905-9. doi: 10.1136/ard.2005.036913

61. Sorensen LK, Havemose-Poulsen A, Sonder SU, et al. Blood cell gene expression profiling in subjects with aggressive periodontitis and chronic arthritis. J Periodontol. 2008;79(3):477-85.

62. doi: 10.1902/jop.2008.070309

63. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol. 2008;79:1585-91. doi: 10.1902/jop.2008.080183

64. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429-42. doi: 10.1038/nri2094

65. Sorsa T, Tjä derhane L, Konttinen YT, et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med. 2006;38(5):306-21. doi: 10.1080/07853890600800103

66. Jeffcoat MK, Geurs NC, Lewis CE Osteoporosis and periodontal bone loss. Clin Calcium. 2003;13(5):577-81.

67. Mayer Y, Balbir-Gurman A, Machtei EE. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. J Periodontol. 2009;80(9):1414-20.

68. doi: 10.1902/jop.2009.090015

69. Novo E, Garcia-MacGregor E, Viera N, et al. Periodontitis and anti-neutrophil cytoplasmic antibodies in systemic lupus erythematosus and rheumatoid arthritis: a comparative study. J Periodontol. 1999;70:185-8. doi: 10.1902/jop.1999.70.2.185

70. Rzeszutko W, Konopka T, Kopec W. Anti-neutrophil cytoplasmic antibodies and autoantibodies to human heat shock protein 60

71. in periodontitis patients. Adv Clin Exp Med. 2006;15(4):599-605.

72. Gomez-Puerta JA, Bosch X. Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update. Am J Pathol. 2009;175:1790-8. doi: 10.2353/ajpath.2009.090533

73. Kallenberg CG. Pathogenesis of ANCA-associated vasculitis, an update. Clin Rev Allerg Immunol. 2011;41(2):224-31. doi: 10.1007/s12016-011-8258-y

74. Rohini NV, Pradeep AR, Faizuddin M. Antineutrophil cytoplasmic antibodies and adult periodontitis. J Periodont Res. 2000;35(6):374-6. doi: 10.1034/j.1600-0765.2000.035006374.x

75. Stewart C, Cohen D, Bhattacharyya I, et al. Oral manifestations of Wegener's granulomatosis: a report of three cases and a literature review. J Am Dent Assoc. 2007;138(3):338-48. doi: 10.14219/jada.archive.2007.0166

76. Patten SF, Tomecki KJ. Wegener's granulomatosis: cutaneous and oral mucosal disease. J Am Acad Dermatol. 1993;28(5):710-8. doi: 10.1016/0190-9622(93)70098-E

77. Cohen RE, Cardoza TT, Drinnan AJ, et al. Gingival manifestations of Wegener's granulomatosis. J Periodontol. 1990;61(11):705-9. doi: 10.1902/jop.1990.61.11.705

78. Shiboski CH, Regezi JA, Sanchez HC, Silverman S Jr. Oral lesions as the first clinical sign of microscopic polyangiitis: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94(6):707-11. doi: 10.1067/moe.2002.129178

79. Xing X, Zhang T, Wang X. Pediatric Wegener's granulomatosis with oral ulcers and progressive periodontitis: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(4):1-5. doi: 10.1016/j.tripleo.2011.05.030

80. Ruokonen H, Helve T, Arola J, et al. «Strawberry like» gingivitis being the first sign of Wegener's granulomatosis. Eur J Intern Med. 2009;20(6):651-3. doi: 10.1016/j.ejim.2009.04.007

81. Siar CH, Yeo KB, Nakano K, et al. Strawberry gingivitis as the first presenting sign of Wegener's granulomatosis: report of a case. Eur J Med Res. 2011;16(7):331-4. doi: 10.1186/2047-783X-16-7-331

82. Aravena V, Beltran V, Cantin M, Fuentes R. Gingival hyperplasia being the first sign of Wegener's granulomatosis. Intern J Clin Exper Med. 2014;7(8):2373-6.

83. Popa ER, Stegeman CA, Abdulahad WH, et al. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatology (Oxford). 2007;46(6):1029-33. doi: 10.1093/rheumatology/kem022

84. Kitagawa K, Furuichi K, Sagara A, et al; Kanazawa Study Group for Renal Diseases and Hypertension. Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis. Clin Exp Nephrol. 2015 Nov 20. [Epub ahead of print]. PubMed PMID: 26590051.

85. Azarpazhooh A, Leake JL. Systematic review of the association between respiratory diseases and oral health. J Periodontol. 2006;77(9):1465-82. doi: 10.1902/jop.2006.060010

86. Scannapieco FA, Ho AW. Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. J Periodontol. 2001;72(1):50-6. doi: 10.1902/jop.2001.72.1.50

87. Mojon P. Oral health and respiratory infection. J Can Dent Assoc. 2002;68(6):340-5.

88. Bosnjak A, Plancak D, Curilovic Z. Advances in the relationship between periodontitis and systemic diseases. Acta Stomatol Croat. 2001;35:267-71.

89. Inoue CN, Matsutani S, Ishidoya M, et al. Impact of periodontal treatment in combination with tonsillectomy plus methylprednisolone pulse therapy and angiotensin blockade for pediatric IgA nephropathy. Clin Nephrol. 2012;77(2):137-45. doi: 10.5414/CN106836

90. Akman A, Kacaroglu H, Donmez L, et al. Relationship between periodontal findings and Behcet's disease: a controlled study. J Clin Periodontol. 2007;34(6):485-91. doi: 10.1111/j.1600-051X.2007.01085.x

91. Karacayli U, Mumcu G, Simsek I, et al. The close association between dental and periodontal treatments and oral ulcer course in Behcet's disease: a prospective clinical study. J Oral Pathol Med. 2009;38(5):410-5. doi: 10.1111/j.1600-0714.2009.00765.x

92. Loo JA, Yan W, Ramachandran P, Wong DT. Comparative human salivary and plasma proteomes. J Dent Res. 2010;89(10):1016-23. doi: 10.1177/0022034510380414

93. Al Kawas S, Rahim ZH, Ferguson DB. Potential uses of human salivary protein and peptide analysis in the diagnosis of disease. Arch Oral Biol. 2012;57(1):1-9. doi: 10.1016/j.archoralbio.2011.06.013

94. Yoshizawa JM, Schafer CA, Schafer JJ, et al. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev. 2013;26(4):781-91. doi: 10.1128/CMR.00021-13

95. Iwasaki K, Okawa-Takatsuji M, Aotsuka S, Ono T. Detection of anti-SS-A/Ro and anti-SS-B/La antibodies of IgA and IgG iso-types in saliva and sera of patients with Sjö gren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi. 2003;26(6):346-54. doi: 10.2177/jsci.26.346

96. Aqrawi LA, Skarstein K, Oijordsbakken G, Brokstad KA. Ro52-and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjö gren's syndrome. Clin Exp Immunol. 2013;172(2):228-37. doi: 10.1111/cei.12058

97. Janket S, Meurman JH, Baird AE, et al. Salivary immunoglobulins and prevalent coronary artery disease. J Dent Res. 2010;89(4):389-94. doi: 10.1177/0022034509359884


Для цитирования:


Бекетова Т.В., Селифанова Е.И. Патология периодонта и системные васкулиты: взгляд сквозь призму междисциплинарных исследований. Научно-практическая ревматология. 2017;55(6):685-689. https://doi.org/10.14412/1995-4484-2017-685-689

For citation:


Beketova T.V., Selifanova E.I. PERIODONTAL DISEASES AND SYSTEMIC VASCULITIS: A VIEW THROUGH THE PRISM OF INTERDISCIPLINARY STUDIES. Rheumatology Science and Practice. 2017;55(6):685-689. (In Russ.) https://doi.org/10.14412/1995-4484-2017-685-689

Просмотров: 240


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)